Effect of simvastatin on cisplatin-induced nephrotoxicity in male rats

Iranian Journal of Pharmaceutical Sciences

Volumn 7, Issue 3, 2011, Pages 165-173

  Khoshnoud, Mohammad Javad ^a   Moghbel, Baligh Naji Abdeh ^a   Geramizadeh, Bita ^b   Niknaha, Hossein ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cisplatin; Nephrotoxicity; Oxidative stress; Simvastatin

Indexed keywords

CISPLATIN; CREATININE; GLUTATHIONE; MALONALDEHYDE; POTASSIUM; SIMVASTATIN; SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; POTASSIUM BLOOD LEVEL; RAT; RENAL PROTECTION; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; TISSUE INJURY; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

EID: 84857754953     PISSN: 17352444     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Schachter, M., Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundamental & clinical pharmacology, 2005. 19(1): p. 117-125.
2. Iseri, S., et al., Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology, 2007. 230(2-3): p. 256-264.
3. Epstein, M. and V.M. Campese, Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function. American journal of kidney diseases, 2005. 45(1): p. 2-14.
4. Miller, R.P., et al., Mechanisms of cisplatin nephrotoxicity. Toxins, 2010. 2(11): p. 2490-2518.
5. Casarett, L.J., C.D. Klaassen, and J. Doull, Casarett and Doull's toxicology: the basic science of poisons. 2008: McGraw-Hill Professional.
6. Ali, B.H. and M.S. Al Moundhri, Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food and chemical toxicology, 2006. 44(8): p. 1173-1183.
7. An, Y., et al., Amelioration of cisplatin-induced nephrotoxicity by pravastatin in mice. Experimental and Toxicologic Pathology, 2010.
8. Owen, J., et al., The determination of creatinine in plasma or serum, and in urine; a critical examination. Biochemical Journal, 1954. 58(3): p. 426.
9. Hosten, A.O., BUN and Creatinine. Clinical Methods, the history, physical and laboratory examinations, part XIV: p. 874-878.
10. Ekor, M., G.O. Emerole, and E.O. Farombi, Phenolic extract of soybean (Glycine max) attenuates cisplatin-induced nephrotoxicity in rats. Food and Chemical Toxicology, 2010. 48(4): p. 1005-1012.
11. de Zwart, L.L., et al., Biomarkers of free radical damage:: Applications in experimental animals and in humans. Free Radical Biology and Medicine, 1999. 26(1-2): p. 202-226.
12. Ohkawa, H., N. Ohishi, and K. Yagi, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 1979. 95(2): p. 351-358.
13. Sedlak, J. and R.H. Lindsay, Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Analytical biochemistry, 1968. 25(1): p. 192.
14. Martindale, S.C. Sweetman, and W. Martindale, The complete drug reference. 2005: Pharmaceutical Press (2002). Martindale: The complete drug reference, thirty-fifth edition, London.
15. Launay-Vacher, V., et al., Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer chemotherapy and pharmacology, 2008. 61(6): p. 903-909.
16. Hughes, A.K., et al., Effect of reactive oxygen species on endothelin-1 production by human mesangial cells. Kidney international, 1996. 49(1): p. 181-189.
17. Lovri, J., et al., Measurement of malondialdehyde (MDA) level in rat plasma after simvastatin treatment using two different analytical methods. Periodicum biologorum, 2008. 110(1).
18. Coletta Francescato, H.D., et al., Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats. Pharmacological Research, 2001. 43(1): p. 77-82.
19. Saad, A.A., M.I. Youssef, and L.K. El-Shennawy, Cisplatin induced damage in kidney genomic DNA and nephrotoxicity in male rats: The protective effect of grape seed proanthocyanidin extract. Food and Chemical Toxicology, 2009. 47(7): p. 1499-1506.
20. Sueishi, K., et al., Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. European journal of pharmacology, 2002. 451(2): p. 203-208.
21. Mittler, R., Oxidative stress, antioxidants and stress tolerance. Trends in plant science, 2002. 7(9): p. 405-410.
22. Gutteridge, J., Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clinical Chemistry, 1995. 41(12): p. 1819.
23. Iseri, S., F. Ercan, and N. Gedik, Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology, 2007. 230(2-3): p. 256-264.
24. Bagchi, D., et al., Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. General pharmacology, 1998. 30(5): p. 771-776.
25. Suzuki, C.A.M. and M. Cherian, The interactions of cis-diamminedichloroplatinum with metalloth-ionein and glutathione in rat liver and kidney. Toxicology, 1990. 64(2): p. 113-127.
26. Montine, T.J. and R.F. Borch, Role of endogenous sulfur-containing nucleophiles in an in vitro model of cis-diamminedichloroplatinum (II)-induced nephrotoxicity. Biochemical pharmacology, 1990. 39(11): p. 1751-1757.
27. Meyer, K. and N. Madias, Cisplatin nephrotoxicity. Mineral and electrolyte metabolism, 1994. 20(4): p. 201.
28. GREGGI ANTUNES, L.M. and C.D. D'ARC, PROTECTIVE EFFECTS OF VITAMIN C AGAINST CISPLATIN-INDUCED NEPHROTOXICITY AND LIPID PEROXIDATION IN ADULT RATS: A DOSE-DEPENDENT STUDY* 1. Pharmacological Research, 2000. 41(4): p. 405-411.
29. Schupp, N., et al., Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis. Atherosclerosis, 2008. 199(2): p. 278-287.
30. Athyros, V., et al., The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. Journal of clinical pathology, 2004. 57(7): p. 728.
31. Shepherd, J., et al., Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clinical Journal of the American Society of Nephrology, 2007. 2(6): p. 1131.
32. Zhou, M.S., et al., Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-, and fibronectin with concomitant increase in nitric oxide bioavailability. American Journal of Physiology-Renal Physiology, 2008. 295(1): p. F53.